Ondansetron ODT 8 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26F4YWQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,071
Award facts
- Contract value 100% obligated
- $5,071.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30, with a contract ceiling value of $5,071.03. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for completion by November 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supply support to federal agencies, particularly the Defense Health Agency and military healthcare systems. The company maintains an extensive portfolio of pharmaceutical products and medical supplies through its DLA prime contract, which encompasses specialty medications, brand-name and generic drugs, vaccines, and other healthcare commodities across multiple therapeutic domains. This delivery order for ondansetron, an antiemetic medication commonly used in military and veteran healthcare settings, represents a routine transaction within AmerisourceBergen's established federal medical procurement operations and demonstrates the company's continued role as a key vendor for Department of Defense pharmaceutical supply chain requirements.
Quick answers
Who was awarded contract SPE2DR26F4YWQ?
SPE2DR26F4YWQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26F4YWQ worth?
The government has obligated $5,071 on SPE2DR26F4YWQ.
Is contract SPE2DR26F4YWQ an order under another contract?
Yes. SPE2DR26F4YWQ is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4YWQ competed?
The extent of competition for SPE2DR26F4YWQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award